⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL11113836 | 0.97 | — | — | |
| SCHEMBL10393354 | 0.77 | — | — | |
| SCHEMBL10392587 | 0.71 | — | — | |
| SCHEMBL27817344 | 0.71 | — | — | |
| SCHEMBL21680850 | 0.71 | — | — | |
| Hydrochloric Acid SCHEMBL11110993 | 0.69 | — | — | |
| SCHEMBL10392568 | 0.69 | — | — | |
| SCHEMBL37216 | 0.67 | — | — | |
| SCHEMBL13186079 | 0.67 | — | — | |
| SCHEMBL27416315 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3898841-A1 | ASYMMETRIC RHODAMINE DYE AND USE THEREOF IN BIOLOGICAL ASSAYS | Life Technologies Corporation (US) | 2021-10-27 | — | — | EP | disclosed |
| EP-3898842-A1 | MODIFIED RHODAMINE DYE AND USE THEREOF IN BIOLOGICAL ASSAYS | Life Technologies Corporation (US) | 2021-10-27 | — | — | EP | disclosed |
| WO-2020132607-A9 | ASYMMETRIC RHODAMINE DYE AND USE THEREOF IN BIOLOGICAL ASSAYS | Life Technologies Corporation (US) | 2020-11-26 | — | — | WO | disclosed |
| WO-2020132607-A1 | ASYMMETRIC RHODAMINE DYE AND USE THEREOF IN BIOLOGICAL ASSAYS | Life Technologies Corporation (US) | 2020-06-25 | — | — | WO | disclosed |
| WO-2020132487-A1 | MODIFIED RHODAMINE DYE AND USE THEREOF IN BIOLOGICAL ASSAYS | Life Technologies Corporation (US) | 2020-06-25 | — | — | WO | disclosed |
| US-6232076-B1 | REDUCING DEGRADATION OF FLUORESCENT DYE-LABELED POLYMERASE EXTENSION BY ADDING FORMAMIDE | GENAISSANCE PHARMACEUTICALS, INC. | 2001-05-15 | — | — | US | disclosed |
| EP-0327924-A1 | Use of sulfur containing N-organooxycarbamic acid esters for the control of endoparasites, N-organo-oxycarbamic acid esters and process for their preparation | BAYER AG (DE) | 1989-08-16 | — | — | EP | disclosed |